Home » IPO Articles

TPG RE Finance Trust (TRTX) Announces July 20th IPO

TPG RE Finance Trust (TRTX) is planning to raise $226 million in an IPO on Thursday, July 20th, IPO Scoop reports. The company plans to issue 11,000,000 shares at a price of $20.00-$21.00 per share. In the last twelve months, TPG RE Finance Trust generated $167.8 million in revenue and $77.2 million in net income. TPG RE Finance Trust has a market-cap of $1.2 billion. BofA Merrill Lynch, Citigroup, Goldman Sachs, Wells Fargo Securities, Deutsche Bank Securities, J. P. Morgan, Morgan Stanley and Barclays acted as the underwriters for the IPO and... 
 

Calyxt (CLXT) to Raise $101 Million in IPO

Calyxt (CLXT) plans to raise $101 million in an IPO on Thursday, July 20th, IPO Scoop reports. The company will issue 6,100,000 shares at $15.00-$18.00 per share. In the last twelve months, Calyxt generated $30,000 in revenue and had a net loss of $12.3 million. The company has a market cap of $439.9 million. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers. Calyxt provided the following description of their company for its IPO: “We... 
 

Kala Pharmaceuticals (KALA) to Raise $90 Million in IPO

Kala Pharmaceuticals (KALA) is planning to raise $90 million in an initial public offering (IPO) on Thursday, July 20th, IPO Scoop reports. The company will issue 6,000,000 shares at a price of $14.00-$16.00 per share. The company has a market cap of $349.2 million. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Wedbush PacGrow were co-managers. Kala Pharmaceuticals provided the following description of their company for its IPO: “We are a biopharmaceutical company focused on the development... 
 

Co-Diagnostics Plans $9 Million IPO for July 12th (CODX)

Co-Diagnostics (CODX) is planning to raise $9 million in an initial public offering on Wednesday, July 12th, IPO Scoop reports. The company plans to issue 1,300,000 shares at a price of $6.35-$6.75 per share. The company has a market cap of $64.7 million. WallachBeth Capital and Network 1 Securities served as the underwriters for the IPO. Co-Diagnostics provided the following description of their company for its IPO: “Co-Diagnostics, Inc. (“Company,” or “CDI,”), a Utah corporation, is a molecular diagnostics company that has developed,... 
 
© 2006-2017 Ticker Report. Google+.